Not Signed In - CardioDynamics Commences Landmark PREVENT-HF Trial Designed By Leading Heart Failure Specialists
Tue, 06 Mar 2007 08:00 AM EST
... CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced commencement of the PREVENT-HF trial, a multinational randomized controlled trial evaluating whether serial BioZ monitoring in chronic heart failure management will delay or prevent heart failure-related hospitalizations compared to standard clinical care. [click link for full article] ...
Related Topics
- Congestive Heart Failure
- Clinical Trials
- Heart Disease
- Kidney Failure
- Coronary Heart Disease
- Heart Defects
- Heart Murmur
- Heart Diseases
- BNP
- Right-sided heart failure
- Heart and Circulation
- Heart Attack
- Left-sided heart failure
- Heart failure or abnormal rhythm
- Congestive heart failure (rare)
- Congenital Heart Disease
- Heart Bypass Surgery
- Carvedilol
- Heart Diseases--Prevention
- Perforation of the colon leading to peritonitis
email this page
print this page
bookmark this page
feedback on this page
